CNE000000P61
CNE000000P61
SHANDONG LUKANG PHARMACEUTICAL
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 8.65B EUR | 7.12B EUR | 8.68B EUR |
Enterprise Value | 9.25B EUR | 7.56B EUR | 9.21B EUR |
Valuation Multiples | |||
Trailing P/E | 63.69x | 51.77x | 66.12x |
Forward P/E | 14.28x | -- | -- |
Price to Sales | 1.48x | 1.21x | 1.47x |
Price to Book | 1.65x | 1.35x | 1.68x |
EV/Revenue | 1.58x | 1.29x | 1.56x |
EV/EBITDA | 14.49x | 22.32x | 28.45x |
Price to FCF (P/FCF) | 12.29x | 10.87x | 15.32x |
EV/FCF | 13.14x | 11.55x | 16.27x |
FCF Yield | 8.14% | 9.2% | 6.53% |